TIM-3 and LAG-3 checkpoints: Into the clinic and back to the bench

Date 09 December 2017
Event ESMO Immuno-Oncology Congress 2017
Session Immuno-oncology: State of the art I
Topics Cytotoxic agents
Soft Tissue Sarcomas
Sarcoma
Therapy
Biological therapy
Presenter Catherine Sabatos-Peyton
Authors C. Sabatos-Peyton
  • -, Novartis Institutes for BioMedical Research, 02139 - Cambridge/US